PLEC (Plectin) was further found to be up-regulated in squamous cell carcinoma, aiding in the induction of malignant transformation from sinonasal inverted papilloma [41] and has been utilised in pancreatic cancer detection using targeted nanoparticles [42–44]. Here, PLEC is linked to pancreatic neoplasm.